G1 Therapeutics Inc (GTHX)
4.27
-0.22
(-4.90%)
USD |
NASDAQ |
May 06, 16:00
4.275
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Gross Profit (TTM): 77.23M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 77.23M |
December 31, 2023 | 75.32M |
September 30, 2023 | 70.96M |
June 30, 2023 | 84.20M |
March 31, 2023 | 52.81M |
December 31, 2022 | 47.55M |
September 30, 2022 | 43.72M |
Date | Value |
---|---|
June 30, 2022 | 25.52M |
March 31, 2022 | 21.72M |
December 31, 2021 | 29.46M |
September 30, 2021 | 40.58M |
June 30, 2021 | 62.92M |
March 31, 2021 | 59.26M |
December 31, 2020 | 45.28M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
21.72M
Minimum
Mar 2022
84.20M
Maximum
Jun 2023
52.61M
Average
50.18M
Median
Gross Profit (TTM) Benchmarks
Amicus Therapeutics Inc | 362.03M |
Geron Corp | -- |
Palatin Technologies Inc | 6.767M |
Oragenics Inc | -- |
TG Therapeutics Inc | 270.62M |